3-Hydroxypyrimidine-2,4-Diones as Novel Hepatitis B Virus Antivirals Targeting the Viral Ribonuclease H

Andrew D. Huber, Eleftherios Michailidis, Jing Tang, Maritza Puray‐Chavez, Maria Boftsi, Jennifer J. Wolf, Kelsey N. Boschert, Megan A. Sheridan, Maxwell D. Leslie, Karen A. Kirby,

Antimicrobial Agents and Chemotherapy · 2017 · 23 citations · 16 references

DOIFull text

Open access

Concepts

Abstract

Hepatitis B virus (HBV) RNase H (RNH) is an appealing therapeutic target due to its essential role in viral replication. RNH inhibitors (RNHIs) could help to more effectively control HBV infections. Here, we report 3-hydroxypyrimidine-2,4-diones as novel HBV RNHIs with antiviral activity. We synthesized and tested 52 analogs and found 4 that inhibit HBV RNH activity in infected cells. Importantly, 2 of these compounds inhibited HBV replication in the low micromolar range.

References

16